» Articles » PMID: 28983406

Mutation Analysis of the Gene in Iranian Patients with Infantile Nephropathic Cystinosis: Identification of Two Novel Mutations

Overview
Journal Hum Genome Var
Date 2017 Oct 7
PMID 28983406
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Nephropathic cystinosis is an inherited lysosomal transport disorder caused by mutations in the gene that encodes for a lysosomal membrane transporter, cystinosin. Dysfunction in this protein leads to cystine accumulation in the cells of different organs. The accumulation of cystine in the kidneys becomes apparent with renal tubular Fanconi syndrome between 6 and 12 months of age and leads to renal failure in the first decade of life. The aim of this study was to analyze the mutations in 20 Iranian patients, from 20 unrelated families, all of whom were afflicted with infantile nephropathic cystinosis. In these patients, seven different mutant alleles were found, including two new mutations, c.517T>C; p.Y173H and c.492_515del, that have not been previously reported. In addition, we observed that c.681G>A, the common Middle Eastern mutation, was the most common mutation in our patients. Moreover, a new minisatellite or variable number of tandem repeat marker (KX499495) was identified at the gene. Seven different alleles were found for this marker, and its allele frequency and heterozygosity degree were calculated in cystinosis patients and healthy individuals.

Citing Articles

Residual Cystine Transport Activity for Specific Infantile and Juvenile Mutations in a PTEC-Based Addback Model.

Medaer L, David D, Smits M, Levtchenko E, Sampaolesi M, Gijsbers R Cells. 2024; 13(7.

PMID: 38607085 PMC: 11011962. DOI: 10.3390/cells13070646.


CTNS Mutations Causing Autosomal Recessive Cystinosis in a Subset of Iranian Population: Report of Two New Variants.

Mohammadi Chermahini Z, Salehi M, Gheissari A, Ahmadi Beni F, Khosravian F, Kazemi M Adv Biomed Res. 2024; 13:2.

PMID: 38525388 PMC: 10958734. DOI: 10.4103/abr.abr_149_23.


Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.

Fleige T, Burggraf S, Czibere L, Haring J, Gluck B, Keitel L Eur J Hum Genet. 2019; 28(2):193-201.

PMID: 31570786 PMC: 6974606. DOI: 10.1038/s41431-019-0521-3.


A 57 kB Genomic Deletion Causing CTNS Loss of Function Contributes to the Mutational Spectrum in the Middle East.

Najafi M, Kordi Tamandani D, Azarfar A, Bakey Z, Behjati F, Antony D Front Pediatr. 2019; 7:89.

PMID: 30949462 PMC: 6437787. DOI: 10.3389/fped.2019.00089.

References
1.
Anikster Y, Lucero C, Touchman J, Huizing M, McDowell G, Shotelersuk V . Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab. 1999; 66(2):111-6. DOI: 10.1006/mgme.1998.2790. View

2.
Efstratiadis A, Posakony J, Maniatis T, Lawn R, OConnell C, Spritz R . The structure and evolution of the human beta-globin gene family. Cell. 1980; 21(3):653-68. DOI: 10.1016/0092-8674(80)90429-8. View

3.
Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I . CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet. 1998; 63(5):1352-62. PMC: 1377545. DOI: 10.1086/302118. View

4.
Aldahmesh M, Humeidan A, Almojalli H, Khan A, Rajab M, AL-Abbad A . Characterization of CTNS mutations in Arab patients with cystinosis. Ophthalmic Genet. 2009; 30(4):185-9. DOI: 10.3109/13816810903200953. View

5.
Chan A, Lynch M, Bailey J, EZRIN C, Fraser D . Hypothyroidism in cystinosis. A clinical, endocrinologic and histologic study involving sixteen patients with cystinosis. Am J Med. 1970; 48(6):678-92. DOI: 10.1016/s0002-9343(70)80002-x. View